PCC 2.22% 22.0¢ probiomics limited

flu vax trial, page-8

  1. 5,819 Posts.
    lightbulb Created with Sketch. 112
    Yep I would agree with that. In any event the raising will be small and if it is I then think that Biogai will most certainly come on with a further injection of funds in April as outlined previously. I certainly wouldn't want to be putting capital in to a company that has had several raisings to see the share price diminish further as has happened. I'm also very sure that the flu results if as good as they may seem will maybe put other companies into the loop. It would also make it more compelling for Bio to get involved and would think that they too would be reviewing the data from this trial as a sweetener.
 
watchlist Created with Sketch. Add PCC (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.